These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25468094)

  • 1. Bivalirudin and transcatheter aortic valve replacement: a cautionary tale.
    Sangani NK; Greason KL; Torres NE; Suri RM; Mathew V
    Ann Thorac Surg; 2014 Dec; 98(6):2214-5. PubMed ID: 25468094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial.
    Dangas GD; Lefèvre T; Kupatt C; Tchetche D; Schäfer U; Dumonteil N; Webb JG; Colombo A; Windecker S; Ten Berg JM; Hildick-Smith D; Mehran R; Boekstegers P; Linke A; Tron C; Van Belle E; Asgar AW; Fach A; Jeger R; Sardella G; Hink HU; Husser O; Grube E; Deliargyris EN; Lechthaler I; Bernstein D; Wijngaard P; Anthopoulos P; Hengstenberg C;
    J Am Coll Cardiol; 2015 Dec; 66(25):2860-2868. PubMed ID: 26477635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass.
    Davis Z; Anderson R; Short D; Garber D; Valgiusti A
    Ann Thorac Surg; 2003 Jan; 75(1):264-5. PubMed ID: 12537226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.
    Linke A; Chandrasekhar J; Sartori S; Lefevre T; van Belle E; Schaefer U; Tchetche D; Sardella G; Webb J; Colombo A; Windecker S; Vogel B; Farhan S; Sorrentino S; Sharma M; Snyder C; Asgar A; Dumonteil N; Tamburino C; Hink U; Violini R; Stella P; Bernstein D; Deliargyris E; Hengstenberg C; Baber U; Mehran R; Anthopoulos P; Dangas G;
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):1016-1026. PubMed ID: 28498562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Fibrin Polymerization During Bivalirudin Anticoagulation for Transcatheter Aortic Valve Replacement.
    Wipfli C; Fitzpatrick MV; Fitzpatrick JK; Taylor BS; Tanaka KA
    J Cardiothorac Vasc Anesth; 2017 Aug; 31(4):e65-e66. PubMed ID: 28583422
    [No Abstract]   [Full Text] [Related]  

  • 6. Transfemoral Transcatheter Aortic Valve Replacement in a Patient With Heparin-Induced Thrombocytopenia: Intraoperative Anticoagulation Management With Bivalirudin (Angiomax).
    Scott B; Tam CW; Moon RS
    J Cardiothorac Vasc Anesth; 2015 Dec; 29(6):1603-5. PubMed ID: 25604599
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebral Embolism During Transcatheter Aortic Valve Replacement: The BRAVO-3 MRI Study.
    Van Belle E; Hengstenberg C; Lefevre T; Kupatt C; Debry N; Husser O; Pontana F; Kuchcinski G; Deliargyris EN; Mehran R; Bernstein D; Anthopoulos P; Dangas GD;
    J Am Coll Cardiol; 2016 Aug; 68(6):589-599. PubMed ID: 27208464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial.
    Chandrasekhar J; Sartori S; Mehran R; Aquino M; Vogel B; Asgar AW; Webb JG; Tchetche D; Dumonteil N; Colombo A; Windecker S; Claessen BE; Ten Berg JM; Hildick-Smith D; Wijngaard P; Lefèvre T; Deliargyris EN; Hengstenberg C; Anthopoulos P; Dangas GD
    Clin Res Cardiol; 2021 May; 110(5):649-657. PubMed ID: 33839885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalirudin anticoagulation for minimal invasive transapical transcatheter aortic valve replacement in a patient with antiphospholipid antibodies.
    Koster A; Ensminger S; Vlachojannis M; Birschmann I
    J Clin Anesth; 2016 Sep; 33():373-5. PubMed ID: 27555195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bivalirudin for anticoagulation during hypothermic cardiopulmonary bypass and recombinant factor VIIa for iatrogenic coagulopathy.
    Nagle EL; Tsu LV; Dager WE
    Ann Pharmacother; 2011 Sep; 45(9):e47. PubMed ID: 21862711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiopulmonary bypass for complex cardiac surgery using bivalirudin anticoagulation in a patient with heparin antibodies.
    Huebler M; Koster A; Buz S; Boettcher W; Hetzer R; Kuppe H; Dyke CM
    J Card Surg; 2006; 21(3):286-8. PubMed ID: 16684064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bivalirudin for anticoagulation in mechanical aortic valve replacement and heparin-induced thrombocytopenia.
    Klein M; Tomer A; Swartz A; Koyffman L; Weksler N
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):331-3. PubMed ID: 16651880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failing transcatheter aortic valve treated by transcatheter aortic valve in transcatheter aortic valve (TAV-in-TAV) implantation: valve safety versus valve durability.
    Vaquerizo B; Martucci G; Buithieu J; de Varennes B; Lachappelle K; Piazza N
    EuroIntervention; 2014 Dec; 10(8):1000. PubMed ID: 25540083
    [No Abstract]   [Full Text] [Related]  

  • 14. First direct aortic retrievable transcatheter aortic valve implantation in humans.
    Chandrasekhar J; Glover C; Labinaz M; Ruel M
    Can J Cardiol; 2014 Nov; 30(11):1461.e9-11. PubMed ID: 25442452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAVI-in-homograft (TiH): open transcatheter aortic valve replacement in calcified aortic homograft case reports.
    Gennari M; Giambuzzi I; Polvani G; Agrifoglio M
    J Cardiothorac Surg; 2019 Nov; 14(1):208. PubMed ID: 31775822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argatroban and bivalirudin compared to unfractionated heparin in preventing thrombus formation on mechanical heart valves. Results of an in-vitro study.
    Maegdefessel L; Linde T; Michel T; Hamilton K; Steinseifer U; Friedrich I; Schubert S; Hauroeder B; Raaz U; Buerke M; Werdan K; Schlitt A
    Thromb Haemost; 2009 Jun; 101(6):1163-9. PubMed ID: 19492162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery.
    Murphy GS; Marymont JH
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):113-26. PubMed ID: 17289495
    [No Abstract]   [Full Text] [Related]  

  • 18. Bivalirudin for prevention of prosthetic valve thrombosis in heparin allergy.
    Palacios-Rubio J; Cano L; Vilacosta I; Vivas D
    J Card Surg; 2013 Sep; 28(5):520-1. PubMed ID: 23909407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter aortic valve replacement for patients with aortic valve stenosis complicated with moyamoya disease.
    Maeda K; Kuratani T; Torikai K; Mizote I; Iritakenishi T; Takeda Y; Nakatani S; Nanto S; Toda K; Sawa Y
    Ann Thorac Surg; 2014 Oct; 98(4):1443-5. PubMed ID: 25282207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bivalirudin on aortic valve intervention outcomes study: a two-centre registry study comparing bivalirudin and unfractionated heparin in balloon aortic valvuloplasty.
    Kini A; Yu J; Cohen MG; Mehran R; Baber U; Sartori S; Vlachojannis GJ; Kovacic JC; Pyo R; O'Neill B; Singh V; Jacobs E; Poludasu S; Moreno P; Kim MC; Krishnan P; Sharma SK; Dangas GD
    EuroIntervention; 2014 Jul; 10(3):312-9. PubMed ID: 24273237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.